Product
Epinastine
1 clinical trial
1 indication
Indication
Allergic ConjunctivitisClinical trial
A Phase 3, Multicenter, Randomized, Double-masked, Active Controlled Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops 0.05% in the Treatment of Chinese Seasonal Allergic Conjunctivitis PatientsStatus: Completed, Estimated PCD: 2023-11-02